FAM
PETX

Fred Alger Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Fred Alger Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25,000
Closed -$234K – 545
2016
Q3 		$234K Buy
+25,000
New +$208K ﹤0.01% 372
2014
Q3 		– Sell
-225,906
Closed -$3.53M – 644
2014
Q2 		$3.53M Sell
225,906
-63,438
-22% -$899K 0.02% 378
2014
Q1 		$5.37M Buy
+289,344
New +$5.8M 0.03% 342

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fred Alger Management's PETX Position: Q4 2016 in Review

Fred Alger Management sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2016, closing a stake of 25,000 shares — an estimated $234K sold.

Fred Alger Management first reported a position in PETX in Q1 2014 and held it in 3 quarters. The position peaked at $5.37M in Q1 2014. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • Fred Alger Management reported no remaining Aratana Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Fred Alger Management sold 25,000 Aratana Therapeutics, Inc. shares in Q4 2016, an estimated $234K.
  • Fred Alger Management first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 3 quarters.
  • Fred Alger Management's Aratana Therapeutics, Inc. position peaked at $5.37M in Q1 2014.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on Fred Alger Management's 13F filing for Q4 2016, filed 14 Feb 2017.